Literature DB >> 6240821

Distribution of ciprofloxacin in the dog prostate and various tissues.

P C Frimodt-Møller, T Dørflinger, P O Madsen.   

Abstract

The distribution in the dog prostate and other tissues of ciprofloxacin, a quinoline carboxylic acid derivative, was investigated in an experimental model. The concentrations in prostatic tissue, prostatic interstitial fluid (PIF), and prostatic secretion (PS) were lower than the corresponding plasma (P) concentrations, as would be expected for an acidic compound. The experiments were carried out under steady state conditions during intravenous infusion in one group of dogs and following gastric administration in another group. During steady state the ciprofloxacin concentrations were significantly higher in PS than in PIF, and the median PS/P ratios were significantly higher than the PIF/P ratios. These concentrations and ratios were compared with those of two other quinoline carboxylic acid derivatives, rosoxacin and norfloxacin. The concentrations of ciprofloxacin in prostatic tissue, PIF, PS, and urine were several times higher than the minimum inhibitory concentrations for most gram-negative pathogens that cause bacterial prostatitis and urinary tract infections. Clinical trials of ciprofloxacin in these diseases are therefore indicated.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6240821     DOI: 10.1007/bf00258036

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  11 in total

1.  Experimental bacterial prostatitis in dogs.

Authors:  A Baumueller; P O Madsen
Journal:  Urol Res       Date:  1977

2.  Chronic bacterial prostatitis and the diffusion of drugs into prostatic fluid.

Authors:  T A Stamey; E M Meares; D G Winningham
Journal:  J Urol       Date:  1970-02       Impact factor: 7.450

3.  Bacteriologic localization patterns in bacterial prostatitis and urethritis.

Authors:  E M Meares; T A Stamey
Journal:  Invest Urol       Date:  1968-03

4.  Pharmacokinetics and tissue penetration of ciprofloxacin.

Authors:  B Crump; R Wise; J Dent
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

5.  Prostatitis syndromes: new perspectives about old woes.

Authors:  E M Meares
Journal:  J Urol       Date:  1980-02       Impact factor: 7.450

6.  The pH of prostatic fluid: a reappraisal and therapeutic implications.

Authors:  W R Fair; J J Cordonnier
Journal:  J Urol       Date:  1978-12       Impact factor: 7.450

7.  Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.

Authors:  H L Muytjens; J van der Ros-van de Repe; G van Veldhuizen
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

8.  Distribution of quinoline carboxylic acid derivatives in the dog prostate.

Authors:  K M Jensen; P O Madsen
Journal:  Prostate       Date:  1983       Impact factor: 4.104

9.  In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.

Authors:  R Wise; J M Andrews; L J Edwards
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

10.  Experimental models for determination of antimicrobials in prostatic tissue, interstitial fluid and secretion.

Authors:  P O Madsen; A Baumueller; U Hoyme
Journal:  Scand J Infect Dis Suppl       Date:  1978
View more
  3 in total

1.  The treatment of chronic bacterial prostatitis.

Authors:  A Pfau
Journal:  Infection       Date:  1991       Impact factor: 3.553

2.  Fleroxacin (Ro 23-6240) distribution in canine prostatic tissue and fluids.

Authors:  T C Gasser; P H Graversen; P O Madsen
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

Review 3.  Quinolones in urology.

Authors:  K T Nielsen; P O Madsen
Journal:  Urol Res       Date:  1989
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.